globalpatients-admin

GP0849D ICD Study US

We are currently searching for patients in the USA who have been told by a physician that they are a candidate for an ICD (implantable defibrillator), or who have recently had an ICD implanted to participate in a 45-minute online interview. As a token of our appreciation for your time, we will send you a 100$ honorarium. For more information, please contact us at judit@global-patients.com

GP0656D CICU caregivers and patients in the US

IQVIATM (www.iqvia.com), a healthcare research firm, is currently conducting a research project with patients who have a history of chronic inducible cold urticaria and/or their caregivers. The research will involve participating in a telephone interview lasting up to 90 minutes. In appreciation of your time, we are offering an honorarium of $185 for each interview. The interview will focus on the understanding of the patient’s experience with chronic inducible cold

GP0511D Melanoma in the US

Global Patients is working with IQVIATM (www.iqvia.com), a healthcare research firm, conducting a research project with patients 18 years of age or older, who have been diagnosed with advanced or metastatic melanoma by their physician. The research will involve participating in two telephone interviews. Each of these interviews will last for approximately 60 minutes. In appreciation of your time, we are offering an electronic gift card voucher of $200. The

GP0299D HFpEF in US

At Global Patients we are running a study on behalf of Clarivate. We are looking for adults in the US who are living with heart failure with preserved ejection fraction (HFpEF) and have a Body Mass Index (BMI) greater than 30.0 to take part in a 90-minute interview. The purpose of the interview is to explore your experience of living with HFpEF and what you would consider to be a

GP1103B Myositis CD in the UK

At Global Patients we are launching a study for adults with Myositis in the UK.
Study participants will be invited to an individual web assisted interview that will take approximately 30 minutes.
In appreciation of their time, each participant will be compensated 75GBP upon completion of the interview.
For more information, please contact us at irina@global-patients.com

GP0509D Type 2 Diabetes + Peripheral Artery Disease patients in US

Clarivate (a research consultancy) are looking for adults in the US who have been diagnosed with all of the following: Type 2 Diabetes (T2DM) AND Peripheral Arterial Disease (PAD) AND “Intermittent claudication,” which means pain in your legs when you’re walking or exercising, which goes away when you rest. If you meet these criteria, Clarivate would like to invite you to take part in one 45-minute interview. The purpose of

GP0235D ALS patients in the US

At Global Patients we are looking for adults in the US who are living with amyotrophic lateral sclerosis (ALS) to take part in a 60-minute interview.

GP0576D HCC study with patients in US

We are looking for adults with Hepatocellular Carcinoma (HCC) in the US to take part in a single 60-minute, online interview. The purpose of the interview is to understand how individuals with HCC experience their condition and their perspectives on treatments. Participation is entirely voluntary, and your personal information will be kept confidential. You will be compensated $185 to thank you for your time. If you are interested in participating

GP0524D Metastatic Pancreatic Cancer in US

Global Patients along with IQVIATM, a worldwide healthcare consulting firm, is currently conducting a research study, to better understand the experience of patients living with metastatic pancreatic cancer. We would like to invite you to participate in this study, which includes a 60-minute semi-structured interview with one of our senior healthcare researchers. The interview will focus on your experience with metastatic pancreatic cancer. We are interested in learning about the

GP0381D ALL patients in US

Global Patients is collaborating on a research study to better understand and assess the experience of patients with acute lymphoblastic leukemia (ALL). The research study is being conducted with IQVIATM, a healthcare research firm (www.iqvia.com), and a pharmaceutical company that is working on developing therapies for patients with ALL. We are seeking patients with ALL who: are age 55 and older are age 40-55 who have comorbidities that make them

GP0519C RCC study in US

At Global Patients we are looking for adults who have been diagnosed with advanced/metastatic Renal cell carcinoma to complete an online survey.
Participants will be asked questions about their experience with renal cell carcinoma and perceptions of treatments.
As a token of appreciation they will be compensated with 50USD upon completion.
If you are interested in participating please contact us at miriam@global-patients.com

GP0548D PTTc et autres pathologies choniques, France

Une étude menée par IQVIA, une société de recherche en soins de santé pour le comte de Takeda, visant à mieux comprendre les facteurs que les patient(e)s prennent en considération lorsqu’ils/elles décident où ils/elles souhaiteront recevoir un traitement par perfusion. A cette fin, l’équipe d’étude invite les patient(e)s à remplir un questionnaire en ligne unique sur les préférences des patient(e)s concernant leurs traitements par perfusion dans différents contextes. L’équipe souhaite

GP0548D PTTc y otras enfermedades crónicas en España

Este estudio realizado por IQVIA, una empresa de investigación en salud, en representación de Takeda, tiene como objetivo entender mejor qué tipo de factores tienen en cuenta los pacientes a la hora de escoger el entorno en el que recibirán un tratamiento de infusión. Para evaluarlo, el equipo del estudio invita a los pacientes a completar una única encuesta en internet que analiza las preferencias del paciente cuando recibe un

GP0548D cTTP in the US

A study conducted by IQVIA, a healthcare research firm on behalf of Takeda, is aiming to better understand the factors patients take into consideration when deciding the setting where to receive an infusion treatment. We are currently searching for cTTP (Congenital thrombotic thrombocytopenic purpura) patients in the US who currently receive infusion treatments into a vein for a 40min online survey. To assess this, the study team is inviting patients to

GP0548D cTTP and related conditions in the UK

A study conducted by IQVIA, a healthcare research firm on behalf of Takeda, is aiming to better understand the factors patients take into consideration when deciding the setting where to receive an infusion treatment. To assess this, the study team is inviting patients to complete a one-time, online survey exploring patient’s preferences for receiving an infusion treatment in different settings. The team is interested in recruiting patients who currently receive

GP0890C Myasthenia Gravis Patient Focus Group in US

RTI International (RTI), a non-profit research organization, is recruiting people to participate in a focus group. You will be asked questions about your experience with Myasthenia Gravis treatment. If you are 18 years or older and have been told by a doctor that you have Myasthenia Gravis, you may qualify. The focus group will take about 90 minutes and you will be required to read some material before the focus